Medtronic ($MDT) got slapped with an FDA warning letter over problems with its Paradigm insulin infusion pumps. I have uploaded one here [embedded content] . Type 1, or juvenile-onset diabetes, is a life-long disorder that commonly manifests in children and adolescents, but onset can occur at any age. Up to 24 basal rates can be set over a 24 hour period. Nipro Diabetes is a division of Nipro Corporation, a large Japanese medical device and supply company. So far, three themes have emerged: some clear differences from other insulin pumps, a focus on simplicity and convenience, and an attention to safety. I have diabetes, I live with it day in day out and I have views about it – the products that I do or don’t use (often this is out of my control anyway) doesn’t matter to them.
All three gave the pumps the thumbs-up. References were screened independently by two authors, and decisions on study selection were recorded. The review also discusses relevant European guidelines